Frankfurt-am-Main, Germany

Stefanie Dimmeler

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Inventor Stefanie Dimmeler: Pioneering Angiogenesis Research

Introduction

Stefanie Dimmeler is a renowned inventor based in Frankfurt-am-Main, Germany. With an impressive portfolio of 11 patents, she has made significant contributions to the field of angiogenesis and vascular biology. Her innovative methods have the potential to revolutionize therapeutic approaches for conditions related to vascularization and tumor growth.

Latest Patents

One of Stefanie's latest patents involves a method for the inhibition of angiogenesis. This invention focuses on influencing the expression of miR-92 in cells. The method comprises two key steps: providing a cell and either reducing or increasing miR-92 expression. By introducing an antisense molecule against miR-92, the invention promotes vascularization or vessel repair. Alternatively, by increasing miR-92 expression using a specific construct, the invention aims to inhibit tumor angiogenesis. This patent also includes a pharmaceutical composition designed to either reduce or increase miR-92 activity in a cell, showcasing her commitment to advancing medical science in this area.

Career Highlights

Stefanie’s professional journey includes notable positions at T2cure GmbH and Siemens Healthcare Diagnostics Products GmbH. Her work in these leading companies has allowed her to refine her expertise in biotechnology and contribute significantly to the development of innovative health solutions.

Collaborations

Throughout her career, Stefanie has collaborated with esteemed colleagues, including Andreas Michael Zeiher and Christopher Heeschen. These partnerships have enabled her to enhance her research and expand the impact of her inventions in the scientific community.

Conclusion

Stefanie Dimmeler embodies the spirit of innovation with her contributions to angiogenesis research. Her latest patents demonstrate her dedication to advancing therapeutic methods for vascular disorders and cancer treatment. Through collaboration and a strong professional background, she continues to inspire future generations of inventors and researchers in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…